These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 9619882)
1. Anti-Jo-1 antibodies in polymyositis or dermatomyositis: evaluation by ELISA using recombinant fusion protein Jo-1 as antigen. Nishikai M; Ohya K; Kosaka M; Akiya K; Tojo T Br J Rheumatol; 1998 Apr; 37(4):357-61. PubMed ID: 9619882 [TBL] [Abstract][Full Text] [Related]
2. Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis. Yamasaki Y; Yamada H; Nozaki T; Akaogi J; Nichols C; Lyons R; Loy AC; Chan EK; Reeves WH; Satoh M Arthritis Rheum; 2006 Jun; 54(6):2004-9. PubMed ID: 16732549 [TBL] [Abstract][Full Text] [Related]
3. Sensitivity and specificity of anti-Jo-1 antibodies in autoimmune diseases with myositis. Vázquez-Abad D; Rothfield NF Arthritis Rheum; 1996 Feb; 39(2):292-6. PubMed ID: 8849382 [TBL] [Abstract][Full Text] [Related]
4. Anti-Jo-1 antibody in patients with polymyositis/dermatomyositis. Leu CC; Lan JL Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Feb; 25(1):41-7. PubMed ID: 1306148 [TBL] [Abstract][Full Text] [Related]
5. Serum levels of B-cell activating factor of the TNF family (BAFF) correlate with anti-Jo-1 autoantibodies levels and disease activity in patients with anti-Jo-1positive polymyositis and dermatomyositis. Kryštůfková O; Hulejová H; Mann HF; Pecha O; Půtová I; Ekholm L; Lundberg IE; Vencovský J Arthritis Res Ther; 2018 Jul; 20(1):158. PubMed ID: 30053824 [TBL] [Abstract][Full Text] [Related]
6. Sera from anti-Jo-1-positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cells. Barbasso Helmers S; Englund P; Engström M; Ahlin E; Fathi M; Janciauskiene S; Heimbürger M; Rönnelid J; Lundberg IE Arthritis Rheum; 2009 Aug; 60(8):2524-30. PubMed ID: 19644880 [TBL] [Abstract][Full Text] [Related]
7. Humoral immunity in polymyositis/dermatomyositis. Targoff IN J Invest Dermatol; 1993 Jan; 100(1):116S-123S. PubMed ID: 8423380 [TBL] [Abstract][Full Text] [Related]
8. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies. Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871 [TBL] [Abstract][Full Text] [Related]
9. Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies. Sato S; Murakami A; Kuwajima A; Takehara K; Mimori T; Kawakami A; Mishima M; Suda T; Seishima M; Fujimoto M; Kuwana M PLoS One; 2016; 11(4):e0154285. PubMed ID: 27115353 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of myositis-specific autoantibody profiles in Japanese patients with polymyositis/dermatomyositis. Temmoku J; Sato S; Fujita Y; Asano T; Suzuki E; Kanno T; Furuya MY; Matsuoka N; Kobayashi H; Watanabe H; Koga T; Shimizu T; Kawakami A; Migita K Medicine (Baltimore); 2019 May; 98(20):e15578. PubMed ID: 31096460 [TBL] [Abstract][Full Text] [Related]
11. An enzyme-linked immunosorbent assay for the detection and quantitation of anti-Jo-1 antibody in human serum. Biswas T; Miller FW; Takagaki Y; Plotz PH J Immunol Methods; 1987 Apr; 98(2):243-8. PubMed ID: 3494784 [TBL] [Abstract][Full Text] [Related]
12. [Cloning and prokaryotic expression of recombinant Jo-1 antigen and identification of its antigen specificity]. Zhao XY; Bi ZL; Wu YH; Xin HT Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Dec; 24(12):1170-3. PubMed ID: 19068203 [TBL] [Abstract][Full Text] [Related]
13. [Autoantibodies specifically detected in patients with polymyositis/dermatomyositis]. Sato S Nihon Rinsho Meneki Gakkai Kaishi; 2006 Apr; 29(2):85-93. PubMed ID: 16651706 [TBL] [Abstract][Full Text] [Related]
14. The association between Mi-2 antibodies and dermatomyositis. Targoff IN; Reichlin M Arthritis Rheum; 1985 Jul; 28(7):796-803. PubMed ID: 2409985 [TBL] [Abstract][Full Text] [Related]
15. A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies. Eloranta ML; Barbasso Helmers S; Ulfgren AK; Rönnblom L; Alm GV; Lundberg IE Arthritis Rheum; 2007 Sep; 56(9):3112-24. PubMed ID: 17763410 [TBL] [Abstract][Full Text] [Related]
16. Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity. Targoff IN; Reichlin M J Immunol; 1987 May; 138(9):2874-82. PubMed ID: 3553328 [TBL] [Abstract][Full Text] [Related]
17. Improved detection of anti-Jo-1 antibody, a marker for myositis, using purified histidyl-tRNA synthetase. Walker EJ; Tymms KE; Webb J; Jeffrey PD J Immunol Methods; 1987 Feb; 96(2):149-56. PubMed ID: 3100649 [TBL] [Abstract][Full Text] [Related]
18. Immunoserological aspects of idiopathic inflammatory muscle disease. Rozman B; Bozic B; Kos-Golja M; Plesivcnik-Novljan M; Kveder T Wien Klin Wochenschr; 2000 Aug; 112(15-16):722-7. PubMed ID: 11020964 [TBL] [Abstract][Full Text] [Related]
19. [The Jo-1 Syndrome--immunological findings and clinical manifestations]. Seiberlich B; Hunzelmann N; Roers A; Weber M; Schulze-Lohoff E Med Klin (Munich); 2005 Mar; 100(3):137-42. PubMed ID: 15966441 [TBL] [Abstract][Full Text] [Related]
20. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease. Hochberg MC; Feldman D; Stevens MB; Arnett FC; Reichlin M J Rheumatol; 1984 Oct; 11(5):663-5. PubMed ID: 6334746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]